Inside Precision Medicine December 12, 2025
Mike May, PhD

How modular platforms, AI, and open ecosystems are reshaping genomic workflows, and why oncology and other fields will feel the impact first

Genomics has undergone a transformation so rapid that even seasoned scientists remark on its velocity. Sequencing costs that seemed impossibly low a decade ago have fallen further still. Spatial and single-cell technologies now populate not just top-tier institutes but mid-size research hospitals. Physicians increasingly expect molecular information at the time of diagnosis, not months later. The scientific imagination has expanded accordingly: whole-genome sequencing for newborn screening, single-cell atlases for entire organs, and tumor profiling in real-time during therapy are now normal.

Yet, amid this acceleration, a curious bottleneck has emerged. Sequencing, once the rate-limiting step, is often the...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Biotechnology, Pharma / Biotech, Technology
What’s new with GLP-1s
Podcast: Medicaid vs. 340B: A Drug Pricing Clash (Sayeh Nikpay)
283: A candid conversation: Physicians on the front lines of GLP‑1 care
BigHat, Revvity Collaborate with Eli Lilly, Immunai Signs Agreement with Bristol Myers Squibb, SandboxAQ Launches New AI Model
Medicare Is Covering GLP-1s – It’s Time to Cover the Care That Makes Them Sustainable

Share Article